American Healthcare REIT: Shareholder Nominations for Board

TL;DR

AHC is detailing how shareholders can nominate directors for the upcoming meeting.

AI Summary

American Healthcare REIT, Inc. filed an 8-K on June 28, 2024, to report shareholder nominations for its upcoming annual meeting. The filing details the process and requirements for shareholders to nominate candidates for the Board of Directors, as per Exchange Act Rule 14a-11.

Why It Matters

This filing outlines the procedures for shareholder involvement in board composition, impacting corporate governance and potential shifts in company leadership.

Risk Assessment

Risk Level: low — The filing is procedural and relates to standard corporate governance practices, not indicating immediate financial distress or significant operational changes.

Key Players & Entities

• American Healthcare REIT, Inc. (company) — Registrant
• June 25, 2024 (date) — Earliest event date
• June 28, 2024 (date) — Filing date
• Exchange Act Rule 14a-11 (regulation) — Governing rule for nominations

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value per share AHR New York Stock

Filing Documents

• ahr-20240625.htm (8-K) — 27KB
• 0001632970-24-000068.txt ( ) — 151KB
• ahr-20240625.xsd (EX-101.SCH) — 2KB
• ahr-20240625_lab.xml (EX-101.LAB) — 22KB
• ahr-20240625_pre.xml (EX-101.PRE) — 13KB
• ahr-20240625_htm.xml (XML) — 3KB

08 Shareholder Director Nominations

Item 5.08 Shareholder Director Nominations. On June 25, 2024, our Board of Directors, or our Board, established November 7, 2024 as the date of our 2024 annual meeting of stockholders, or the 2024 Annual Meeting. Because the date of the 2024 Annual Meeting differs by more than 30 days from the anniversary date of the previous annual meeting of stockholders, previously announced deadlines for any stockholder proposals pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise, are no longer applicable. To be considered for inclusion in this year's proxy materials for the 2024 Annual Meeting pursuant to Rule 14a-8, stockholder proposals must be received by our Secretary at 18191 Von Karman Avenue, Suite 300, Irvine, California 92612 no later than 5:00 p.m., Pacific Time, on July 10, 2024, which we have determined to be a reasonable time before we expect to begin to print and send our proxy materials. In addition to complying with this deadline, stockholder proposals must comply with all applicable U.S. Securities and Exchange Commission, or SEC, rules, including Rule 14a-8, the requirements set forth in our Amended and Restated Bylaws, or the Bylaws, and applicable law. In accordance with the Bylaws, because the date of the 2024 Annual Meeting has been delayed by more than thirty days from the anniversary date of the 2023 Annual Meeting, in order for a stockholder entitled to vote to bring a proposal or submit a nominee for director at the 2024 Annual Meeting, such stockholder must be a stockholder of record on the date of giving such notice and must continue to be a stockholder of record on the date established by our Board as the record date for the determination of stockholders entitled to vote at the 2024 Annual Meeting, and such notice by such stockholder must be received no later than 5:00 p.m., Pacific Time, on the later of the 120th day prior to the date of the 2024 Annual Meeting or the tenth day followi

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. American Healthcare REIT, Inc. June 28, 2024 By: /s/ Danny Prosky Name: Danny Prosky Title: Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR